Wednesday, July 8, 2026

Drug profile · INN

cholestyramine

cholestyramine (CHOLESTYRAMINE) is a bile acids sequestering agent. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 1
Pipeline programs 1
News articles 0
Drug details — cholestyramine
US status
approved
Class
Route
ORAL
Patents
1
Programs
1
Data quality
0.89

Quick answer

cholestyramine (CHOLESTYRAMINE) is a bile acids sequestering agent. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN cholestyramine
Brand CHOLESTYRAMINE
Mechanism Bile acids sequestering agent
Target Bile acids
Route ORAL
Formulation POWDER

Mechanism of action

Bile acids sequestering agent

Primary target: Bile acids

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Light Power Density and Light Duration 40 mW/cm²*1000s Phase 1 · First People's Hospital · Healthy Adult Subjects

Related & competitor drugs

  1. colesevelam hydrochloride Bile acids sequestering agent
  2. colestipol hydrochloride Bile acids sequestering agent
  3. colestyramine Bile acids sequestering agent
  1. US 9205094

    Compositions comprising bile acid sequestrants for treating esophageal disorders

    Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is cholestyramine?

cholestyramine (CHOLESTYRAMINE) is a bile acids sequestering agent. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for cholestyramine?

CHOLESTYRAMINE is a marketed brand name for cholestyramine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of cholestyramine?

cholestyramine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.